DOSSIER · 13F Holders · Q2 2026
BBIO 2.5 03/15/27
BRIDGEBIO PHARMA INC
46 institutions still hold BRIDGEBIO PHARMA INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 10806XAB8·46 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
46 institutions reported BBIO 2.5 03/15/27 in Q2 2026. WOLVERINE ASSET MANAGEMENT LLC leads at 14.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 3
26 more holders available. Log in →